Researchers at Washington University in St. Louis and the National Institutes of Health (NIH) have found that genes that confer the power to destroy tetracycline antibiotics are widespread in bacteria. But the researchers have also created a chemical compound that shields tetracyclines from destruction, restoring the antibiotics lethality. The findings indicate an emerging threat to one of the most widely used classes of antibiotics — but also a promising way to protect against that threat.
- Addition of sintilimab to pemetrexed and platinum improved progression-free survival
- Phase 3 eXalt3 study shows significantly longer progression-free survival
- checkmate 743 shows that dual immunotherapy, nivolumab + ipilimumab
- Scientists discover curious clues in the war between cf bacteria
- Predicting drought in the American West just got more difficult